377 related articles for article (PubMed ID: 22120122)
1. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
3. MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS.
Zaytseva OO; Jansen BC; Hanić M; Mrčela M; Razdorov G; Stojković R; Erhardt J; Brizić I; Jonjić S; Pezer M; Lauc G
Sci Rep; 2018 Sep; 8(1):13688. PubMed ID: 30209257
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
5. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
[TBL] [Abstract][Full Text] [Related]
6. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
7. Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs.
Sinha S; Pipes G; Topp EM; Bondarenko PV; Treuheit MJ; Gadgil HS
J Am Soc Mass Spectrom; 2008 Nov; 19(11):1643-54. PubMed ID: 18707900
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum.
Wuhrer M; Stam JC; van de Geijn FE; Koeleman CA; Verrips CT; Dolhain RJ; Hokke CH; Deelder AM
Proteomics; 2007 Nov; 7(22):4070-81. PubMed ID: 17994628
[TBL] [Abstract][Full Text] [Related]
9. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
10. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
11. Mouse milk immunoglobulin G Fc-linked N-glycosylation nano-LC-MS analysis in a model of vancomycin exposure during pregnancy.
Alhasan MM; Habazin S; Kahhaleh FG; Lauc G; Conrad ML; Novokmet M
Anal Bioanal Chem; 2023 May; 415(12):2239-2247. PubMed ID: 36914840
[TBL] [Abstract][Full Text] [Related]
12. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.
Baković MP; Selman MH; Hoffmann M; Rudan I; Campbell H; Deelder AM; Lauc G; Wuhrer M
J Proteome Res; 2013 Feb; 12(2):821-31. PubMed ID: 23298168
[TBL] [Abstract][Full Text] [Related]
13. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
[TBL] [Abstract][Full Text] [Related]
14. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
[TBL] [Abstract][Full Text] [Related]
15. Coupling porous sheathless interface MS with transient-ITP in neutral capillaries for improved sensitivity in glycopeptide analysis.
Heemskerk AA; Wuhrer M; Busnel JM; Koeleman CA; Selman MH; Vidarsson G; Kapur R; Schoenmaker B; Derks RJ; Deelder AM; Mayboroda OA
Electrophoresis; 2013 Feb; 34(3):383-7. PubMed ID: 23161657
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
[TBL] [Abstract][Full Text] [Related]
17. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation.
Bondt A; Selman MH; Deelder AM; Hazes JM; Willemsen SP; Wuhrer M; Dolhain RJ
J Proteome Res; 2013 Oct; 12(10):4522-31. PubMed ID: 24016253
[TBL] [Abstract][Full Text] [Related]
18. IgG glycosylation analysis.
Huhn C; Selman MH; Ruhaak LR; Deelder AM; Wuhrer M
Proteomics; 2009 Feb; 9(4):882-913. PubMed ID: 19212958
[TBL] [Abstract][Full Text] [Related]
19. The
de Haan N; Reiding KR; Krištić J; Hipgrave Ederveen AL; Lauc G; Wuhrer M
Front Immunol; 2017; 8():608. PubMed ID: 28620376
[No Abstract] [Full Text] [Related]
20. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
